-
Nature Sub-Journal: The largest single-cell RNA sequencing project in history! The first discovery of glioblastoma stem cells is expected to inhibit cancer cells.
Time of Update: 2020-07-17
as part of this work, our research also shows that, unlike decades of dogma, glioblastoma stem cells are the most rapidly dividing cancer cells in tumors, and we have identified new methods for targeting these cells.
-
Nature Sub-Journal: Brown University Study: Medication may improve the effectiveness of cancer immunotherapy.
Time of Update: 2020-07-17
recently, researchers from Brown University in the United States found that drugs that block tumor promoting protein MDM2 can enhance the effectiveness of immunotherapy.
recently, researchers from Brown University in the United States have found that drugs that block tumor promoting protein MDM2 can increase the efficacy of immunotherapy.
-
This home-based screening, done every two years, is effective in reducing colorectal cancer mortality.
Time of Update: 2020-07-17
studies have shown that biennial fecal occult blood test (FOBT) screening can reduce the mortality rate of colorectal cancer (CRC), but the effect of gender and age difference is unknown.
-
Nature Medicine: Heart disease or breast cancer metastasis! For the first time, scientists have found that heart disease reprograms the immune system, leads to a decline in immunity, promotes breast cancer progression and metastasis.
Time of Update: 2020-07-17
they also studied the possible mechanism of heart disease promoting breast cancer progression in mouse models: myocardial infarction (MI) can cause immune cell reprogramming, induce some immune cells to become immunosuppressive phenotype, trigger systemic immune homeostasis imbalance, and accelerate the progress and metastasis of breast cancer.
-
"Second-generation PD-1" helps patients with advanced non-small cell lung cancer survive in the long term.
Time of Update: 2020-07-17
recently, the clinical trial results of m7824 as a second-line treatment for non-small cell lung cancer (NSCLC) were published: the response rate of m7824 was 21.3%, which exceeded the objective response rate (ORR) of 19.4% of pabolizumab [1].
-
Professor Wu Yilong: "A-T" mode creates the longest OS of EGFR mutation-positive late-stage NSCLC, and treatment tends to be precise.
Time of Update: 2020-07-17
both the Japanese nej026 study and the domestic ctong1509 study showed that the first-line treatment with a + T regimen can significantly prolong the progression free survival (PFS) of advanced NSCLC patients with EGFR mutation positive.
-
JAMA Sub-Journal: Garlic Supplement Anti-Gastric Cancer Effect Seine No! Data from 22 years of follow-up in Shandong showed that drinking alcohol offsets the benefits of garlic, and that smoking is associated with a 101 percent increased risk of death from stomach cancer.
Time of Update: 2020-07-17
the researchers found that the three methods of eradication of Helicobacter pylori, vitamin supplements and garlic supplements can effectively reduce the risk of gastric cancer death by 38%, 52% and 34%, respectively.
-
Express . . . Strong teamed up to develop innovative cancer therapies with Sanofi and MD Anderson Cancer Center.
Time of Update: 2020-07-17
"clinical trials not only help us advance new life-saving treatments for patients in need, they also provide us with valuable information on which treatments may be more effective for which patients," said funda, MD Anderson Cancer Center chair of research cancer therapy "We are pleased to work with Sanofi to accelerate the development of innovative cancer therapy pipelines," said Dr. meric bernstam.
-
Sci Trans Med: The "partner" of anti-tumor immunotherapy has been found!
Time of Update: 2020-07-16
!---- In recent years, the rapid development of tumor immunotherapy has led to a major breakthrough in the field of tumor therapy , the use of immunocheckpoint inhibitors to release anti-tumor immune
-
Cell: Major development, Chinese scientists reveal full map of lung adenocarcinoma proteomics for the first time
Time of Update: 2020-07-16
The !---- introduction: Lung cancer is one of the most common and death-threatening malignancys lung adenocarcinoma (LUAD) accounts for about half of all lung cancers recently, scientists from the C
-
Nature Cancer: Chinese Academy of Sciences Yu Huiyong team report: aldehyde ketone sase B through metabolic reprogramming to inhibit the occurrence of liver cancer
Time of Update: 2020-07-16
!---- metabolic reprogramming is the core marker of cancer, but its definition in the occurrence of hepatocellular carcinoma (HCC) is still vague recently, a team from the Shanghai Institute of Nutri
-
Interview with Professor Xu Wengui: In the Age of Nuclear Medicine, Cancer Is Not Terrible
Time of Update: 2020-07-16
How common are !---- tumors? National cancer data from the National Cancer Center tells us that about 4 million people with malignant tumors nationwide in 2019, an average of about 10,000 families a d
-
Nat Commun: The largest single-cell RNA sequencing project in history! First discovery of glioblastoma stem cells, promising to suppress cancer cells
Time of Update: 2020-07-16
!---- introduction: glioblastoma is the most malignant glioma in astrocyte tumors, the growth rate is extremely fast, 70% to 80% of patients in 3 to 6 months, the course of the disease more than 1 yea
-
Diagn Cytopathol: Bethesda System Reports Use of Thyroid Cell Pathology in Chinese Group
Time of Update: 2020-07-16
The !---- Thyroid Cell Pathology Reporting System (TBSRTC) has been widely used since its introduction in this study, we aim to report on our experience with the use of the reporting system in a larg
-
Professor Zhu Xiuxuan, Jiahui International Hospital: The success of IMbrave150 opens a "skylight" for the immunotherapy of liver cancer
Time of Update: 2020-07-16
!---- recently published in the New England Journal of Medicine (NEJM), the results of the IMbrave150 study show that the combined immune treatment can be successful in liver cancer the lead author o
-
JCB: Cancer cells can "turn enemies into friends"
Time of Update: 2020-07-16
Researchers have now discovered a new mechanism by which invasive breast cancer cells evade immune system metastasis or spread to other parts of the body !---- this helps develop treatments that targ
-
Middle-aged man with shoulder and neck soreness mistakenly thought of cervical vertebral disease, but unexpectedly suffered from a rare disease
Time of Update: 2020-07-16
Mr Mao, !---- who was in his prime, initially thought he had a common office disease, cervical vertebral disease, when he first developed symptoms of shoulder and neck soreness, but he didn't expect t
-
Sci Adv: East China Shishi Adeshi Ye Haifeng Team: Developing a Far Red Light-Activated Gene Editing System - FAST
Time of Update: 2020-07-16
Introduction !----: The rapid development of gene editing technology has provided more and more tools for gene functional research , the CRISPR-Cas system is the most widely used gene editing tool re
-
Nature Cancer: Wu Da Zhongbo team reports: Gouclusase USP25 may promote the occurrence of colorectal cancer
Time of Update: 2020-07-16
!---- existing studies have shown that bacterial infections or abnormal colonies in the gastrointestinal system are associated with some inflammatory bowel disease and colorectal cancer recently, the
-
Prostate male patients with prostate prostate in the prostate of atovastatin entry pathways and concentrations
Time of Update: 2020-07-16
Statins have anti-cancer effects on prostate cancer both in and around the body !---- it is not clear whether this is due to systemic cholesterol reduction or direct inhibition of local prostate grow
